Genetic principles enabling the creation of bacteria-based therapeutics
{"Genetic":[0],"engineering":[1],"can":[2,24],"transform":[3],"bacteria":[4,23,53,151],"(including":[5],"Salmonella,":[6],"Escherichia":[7],"coli,":[8],"Listeria,":[9],"and":[10,45,64,78,85,87,92,106,123,133,143,146],"Yersinia)":[11],"from":[12],"naturally":[13],"occurring":[14],"microbes":[15],"into":[16],"programmable":[17],"therapeutics.":[18],"Unlike":[19],"passive":[20],"platforms,":[21],"engineered":[22],"localize":[25],"to":[26,140,157],"defined":[27],"biological":[28],"niches,":[29],"sense":[30],"environmental":[31],"cues,":[32],"regulate":[33],"programmed":[34,150],"activity":[35,65],"in":[36,42,93],"situ,":[37],"interact":[38],"with":[39,120],"host":[40],"tissues":[41],"novel":[43],"ways,":[44],"persist":[46],"for":[47],"controlled":[48],"periods.":[49],"These":[50,96],"properties":[51],"make":[52],"versatile":[54],"medicines":[55],"but":[56],"require":[57],"genetic":[58,130],"control":[59,80],"of":[60,81,109,135,149],"precision,":[61],"safety,":[62],"stability,":[63],"under":[66,111],"clinical":[67,142],"conditions.":[68],"Major":[69],"design":[70,131],"layers":[71],"include":[72],"strain":[73],"or":[74],"\\"chassis\\"":[75],"selection,":[76],"attenuation":[77],"biocontainment,":[79],"therapeutic":[82],"activity,":[83],"targeting":[84],"persistence,":[86],"genotype-to-phenotype":[88],"stability":[89],"during":[90],"manufacturing":[91],"vivo":[94],"use.":[95],"features":[97],"also":[98],"create":[99],"liabilities,":[100],"including":[101],"off-target":[102],"behavior,":[103],"unstable":[104],"expression,":[105],"evolutionary":[107],"loss":[108],"function":[110],"selection.":[112],"Progress":[113],"depends":[114],"on":[115],"safe,":[116],"clinically":[117],"translatable":[118],"chassis":[119],"integrated,":[121],"bounded,":[122],"durable":[124],"behaviors.":[125],"This":[126],"review":[127],"examines":[128],"the":[129,147],"principles":[132],"liabilities":[134],"bacteria-based":[136],"therapeutics,":[137],"approaches":[138],"used":[139],"produce":[141],"near-clinical":[144],"candidates,":[145],"emergence":[148],"delivering":[152],"complete":[153],"gene":[154],"editing":[155],"systems":[156],"therapeutically":[158],"relevant":[159],"cells.":[160]}
Authors
- Thomas M. Groseclose (ORCID: https://orcid.org/0000-0001-7831-4294)
- Ashley B. Williams (ORCID: https://orcid.org/0000-0002-7558-9599)
- Lyndsey Linke
- Darcy S O Mora
- Sara A M Holec
- Darrian Newman
Institutions
- Kai Biotech (South Korea) (KR)
Publication Details
- Journal
- Genetics
- Published
- 2026-09-17
- DOI
- https://doi.org/10.1093/genetics/iyag235
- Primary Topic
- Cancer Research and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- National Institutes of Health
- National Institute of Allergy and Infectious Diseases